Cargando…
Epigenetic-Genetic Chromosome Dosage Approach for Fetal Trisomy 21 Detection Using an Autosomal Genetic Reference Marker
BACKGROUND: The putative promoter of the holocarboxylase synthetase (HLCS) gene on chromosome 21 is hypermethylated in placental tissues and could be detected as a fetal-specific DNA marker in maternal plasma. Detection of fetal trisomy 21 (T21) has been demonstrated by an epigenetic-genetic chromos...
Autores principales: | Tong, Yu K., Chiu, Rossa W. K., Akolekar, Ranjit, Leung, Tak Y., Lau, Tze K., Nicolaides, Kypros H., Lo, Y. M. Dennis |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004793/ https://www.ncbi.nlm.nih.gov/pubmed/21249119 http://dx.doi.org/10.1371/journal.pone.0015244 |
Ejemplares similares
-
Noninvasive Prenatal Diagnosis of Fetal Trisomy 18 and Trisomy 13 by Maternal Plasma DNA Sequencing
por: Chen, Eric Z., et al.
Publicado: (2011) -
Systematic Identification of Placental Epigenetic Signatures for the Noninvasive Prenatal Detection of Edwards Syndrome
por: Tsui, Dana W. Y., et al.
Publicado: (2010) -
Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study
por: Chiu, Rossa W K, et al.
Publicado: (2011) -
Noninvasive Prenatal Diagnosis of Fetal Trisomy 21 by Allelic Ratio Analysis Using Targeted Massively Parallel Sequencing of Maternal Plasma DNA
por: Liao, Gary J. W., et al.
Publicado: (2012) -
Translating Dosage Compensation to Trisomy 21
por: Jiang, Jun, et al.
Publicado: (2013)